Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
7.0
157.44%
60%
—
98.47%
80%
—
5 Years
Score7.0
Net Growth157.44%
Net Trend60%
Net Income Consistency—
Rev Growth98.47%
Rev Trend80%
Revenue Consistency—
Theravance Biopharma Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 71M to $ 107M and net income went from -$ 278M to $ 105M. Revenue increased in 4 of those 5 years; net income in 3.
Across Theravance Biopharma Inc's full reported history, from 2014 to 2025, revenue grew from $ 11M to $ 107M and net income went from -$ 237M to $ 105M. Revenue increased in 67% of the years measured; net income in 50%.
Theravance Biopharma Inc currently holds a 5-year HDB Score of 7.0 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 16.92 | — |
1 Year2025-08-12 | $ 11.92 | 41.95% |
5 Years2021-08-12 | $ 13.34 | 26.84% |
10 Years2016-08-12 | $ 26.96 | -37.24% |
All Time2014-05-16 | $ 22.96 | -26.31% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | All Time2014-05-16 |
|---|---|---|---|---|---|
| Price | $ 16.92 | $ 11.92 | $ 13.34 | $ 26.96 | $ 22.96 |
| Return | — | 41.95% | 26.84% | -37.24% | -26.31% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 109M | $ 114M | $ 394M |
| 2025 | $ 107M | $ 105M | $ 315M |
| 2024 | $ 64M | -$ 56M | $ 88M |
| 2023 | $ 57M | -$ 55M | $ 102M |
| 2022 | $ 51M | $ 872M | $ 327M |
| 2021 | $ 55M | -$ 199M | $ 173M |
| 2020 | $ 71M | -$ 278M | $ 292M |
| 2019 | $ 73M | -$ 236M | $ 280M |
| 2018 | $ 60M | -$ 215M | $ 505M |
| 2017 | $ 15M | -$ 285M | $ 348M |
| 2016 | $ 48M | -$ 190M | $ 501M |
| 2015 | $ 42M | -$ 182M | $ 172M |
| IPO2014 | $ 11M | -$ 237M | $ 306M |
Explore beyond TBPH
You're looking at Theravance Biopharma Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
